- Home
- BL vs ALVO Comparison
BL vs ALVO Comparison
Compare BL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BL
- ALVO
- Stock Information
- Founded
- BL 2001
- ALVO 2013
- Country
- BL United States
- ALVO Luxembourg
- Employees
- BL N/A
- ALVO N/A
- Industry
- BL Computer Software: Prepackaged Software
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- BL Technology
- ALVO Health Care
- Exchange
- BL Nasdaq
- ALVO Nasdaq
- Market Cap
- BL 2.9B
- ALVO 2.5B
- IPO Year
- BL 2016
- ALVO N/A
- Fundamental
- Price
- BL $52.96
- ALVO $9.38
- Analyst Decision
- BL Buy
- ALVO Buy
- Analyst Count
- BL 12
- ALVO 1
- Target Price
- BL $60.75
- ALVO $18.00
- AVG Volume (30 Days)
- BL 678.1K
- ALVO 140.4K
- Earning Date
- BL 05-06-2025
- ALVO 05-07-2025
- Dividend Yield
- BL N/A
- ALVO N/A
- EPS Growth
- BL 28.24
- ALVO N/A
- EPS
- BL 1.41
- ALVO 0.34
- Revenue
- BL $662,806,000.00
- ALVO $587,890,000.00
- Revenue This Year
- BL $10.40
- ALVO $33.92
- Revenue Next Year
- BL $9.23
- ALVO $45.74
- P/E Ratio
- BL $35.89
- ALVO $27.67
- Revenue Growth
- BL 8.93
- ALVO 413.92
- 52 Week Low
- BL $40.82
- ALVO $7.35
- 52 Week High
- BL $66.25
- ALVO $14.65
- Technical
- Relative Strength Index (RSI)
- BL 70.08
- ALVO 58.67
- Support Level
- BL $46.37
- ALVO $7.90
- Resistance Level
- BL $48.04
- ALVO $8.50
- Average True Range (ATR)
- BL 1.39
- ALVO 0.39
- MACD
- BL 0.78
- ALVO 0.18
- Stochastic Oscillator
- BL 96.45
- ALVO 67.72
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.